Nocturnal hormone secretion in patients with schizophrenia with predominantly negative symptoms treated with olanzapine

被引：0
|
作者：
Mann, K [1 ]
Rossbach, W [1 ]
Müller, MJ [1 ]
Müller-Siecheneder, F [1 ]
Pott, T [1 ]
Russ, H [1 ]
Dittmann, RW [1 ]
Hiemke, C [1 ]
机构：
[1] Univ Mainz, D-6500 Mainz, Germany
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S235 / S235
页数：1
相关论文
共 50 条
  • [1] Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine
    Mann, K
    Rossbach, W
    Müller, MJ
    Müller-Siecheneder, F
    Pott, T
    Linde, I
    Dittmann, RW
    Hiemke, C
    PSYCHONEUROENDOCRINOLOGY, 2006, 31 (02) : 256 - 264
  • [2] Central serotonergic function in patients with predominantly negative symptoms of schizophrenia
    Uhl, I.
    Kulik, A.
    Roser, P.
    Theodoridou, A.
    Wyss, C.
    Norra, C.
    Bruene, M.
    Kawohl, W.
    Juckel, G.
    SCHIZOPHRENIA RESEARCH, 2018, 193 : 443 - 444
  • [3] Quetiapine versus olanzapine for the treatment of negative symptoms in patients with schizophrenia
    Sirota, Pinkhas
    Pannet, Irit
    Koren, Ady
    Tchernichovsky, Eieonora
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2006, 21 (04) : 227 - 234
  • [4] Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms
    Müller, MJ
    Rossbach, W
    Röschke, J
    Müller-Siecheneder, F
    Blümler, M
    Wetzel, H
    Russ, H
    Dittmann, RW
    Benkert, O
    PHARMACOPSYCHIATRY, 2004, 37 (04) : 157 - 162
  • [5] The effectiveness of quetiapine versus olanzapine in improving negative symptoms of patients with schizophrenia
    Sirota, P
    Tchernichowsky, E
    Panet, I
    Koren, A
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 170 - 170
  • [6] Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms
    Riedel, Michael
    Spellmann, Ilja
    Strassnig, Martin
    Douhet, Anette
    Dehning, Sandra
    Opgen-Rhein, Markus
    Valdevit, Rosamaria
    Engel, Rolf R.
    Kleindienst, Nikolaus
    Mueller, Norbert
    Moeller, Hans-Juergen
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2007, 257 (06) : 360 - 370
  • [7] Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms
    Michael Riedel
    Ilja Spellmann
    Martin Strassnig
    Anette Douhet
    Sandra Dehning
    Markus Opgen-Rhein
    Rosamaria Valdevit
    Rolf R. Engel
    Nikolaus Kleindienst
    Norbert Müller
    Hans-Jürgen Möller
    European Archives of Psychiatry and Clinical Neuroscience, 2007, 257 : 360 - 370
  • [8] Asenapine versus olanzapine in patients with predominant, persistent negative symptoms of schizophrenia
    Cazorla, P.
    Panagides, J.
    Alphs, L.
    Kouassi, A.
    Buchanan, R.
    Szegedi, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 138 - 139
  • [9] Real-world Effectiveness of Antipsychotics for the Treatment of Negative Symptoms in Patients with Schizophrenia with Predominantly Negative Symptoms
    Novick, Diego
    Montgomery, William
    Treuer, Tamas
    Victoria Moneta, Maria
    Maria Haro, Josep
    PHARMACOPSYCHIATRY, 2017, 50 (02) : 56 - 63
  • [10] Manic-like symptoms in patients with schizophrenia treated with olanzapine, haloperidol, and placebo
    Baker, RW
    McElroy, SL
    Juliar, BE
    Schuh, LM
    Shao, L
    Stauffer, VL
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 195 - 196
12345